HUS introduces new screening method for lymphatic disorders

New Children's Hospital has introduced a new screening method that identifies lymphatic disorders and provides more possibilities for treating the most severe heart diseases in children, said Helsinki-Uusimaa Hospital District (HUS) in a press release on Monday.

About 450 children are born with a congenital heart defect each year in Finland. About 150 of them need heart surgery during their first year of life. Severe congenital heart diseases may involve lymphatic disorders that can lead to leakages of lymphatic fluid.

These situations are particularly important in the most severe heart defects, because protein loss can cause serious problems in many organ systems.

In the worst case, for example, this can mean that the need for heart transplantation must be considered in patients with a single-ventricle heart.

In cooperation with an international network of experts, HUS has developed a proactive screening method for lymphatic disorders.

“Screening for lymphatic disorders allows us to provide more tailored individual treatment and better assess surgical risks,” said Pediatric Radiologist Laura Martelius of the Diagnostic Center.

“This innovative treatment model opens up completely new possibilities for treating the most severe heart diseases in children. The first patients with severe symptoms have been treated in cooperation with Danish experts,” said Tiina Ojala, head physician and professor of pediatric cardiology of New Children’s Hospital.

According to a study conducted in European pediatric hospitals, diagnostic examinations and interventions related to lymphatic disorders have become more common in children with severe heart disease.

HUS is at the forefront of international development. The screening for lymphatic disorders that was now introduced enables early intervention and risk assessment, which reinforces the importance of the proactive screening method developed by HUS.

“Centralized expertise and the development of new imaging methods are proving to be important factors as we seek new treatment solutions for children with heart disease,” said Ojala.